Regnology Announces its 29 th Annual RegTech Convention on 29 th – 30 th November
Regnology, a leading software provider with an exclusive focus on regulatory reporting solutions has announced its 29th annual RegTech Convention, taking place on the 29th-30th November in Frankfurt, Germany and virtually. The convention will bring together nearly 2,000 delegates across regulatory authorities, supervisory agencies, and financial institutions to explore the evolving trends in regulation.
The theme for this year’s convention is Regulation 3.0, which will be explored across 30 keynotes and panel discussions from leading industry experts and Regnology subject matter experts. Over thirty external speakers will discuss how the regulatory complexity for financial institutions can be reduced in view of a challenging global economic environment, the pressure to maximize cost efficiencies, and an evolving financial market landscape.
Fredrik Reinfeldt, Swedish prime minister from 2006-2014, will address the current political and economic challenges in Europe and how it affects the topic of regulation in his opening keynote. Additional contributors will include senior leaders from the European Central Bank, BaFin, HSBC, Commerzbank, Google, and IBM.
Participants will benefit from a deep dive on regulation, with sessions covering European reporting, supervisory and regulatory technology trends, including the ‘state of play’ regarding ESG requirements, the institutionalization of crypto assets and Public Cloud. They will also be able to meet with Regnology’s experts during a collection of micro-conferences and educational breakout sessions across banking, transactions, and supervisory tech.
This year’s RegTech convention is the second since the appointment of Regnology CEO Rob Mackay in 2021. Under his leadership, the organization has accelerated a full transformation to position Regnology as a global leader in regulatory technology, underlined by strong corporate values.
The convention will be livestreamed and available on demand following the event.
The full agenda and registration can be found at: https://www.regtech-convention.com/en/agenda/
RegTech 2022 speakers include:
- Fredrik Reinfeldt, Former Swedish prime minister from 2006-2014 and member of the European Council
- Markus Cevela, Managing Director / Head of Statutory Reporting Austria, Erste Group Services GmbH
- Sidhartha Dash, Chief Researcher, Chartis Research
- Martina Drvar, Advisor, European Central Bank
- Nils Gerstengarbe, Chapter Lead, Commerzbank
- Naja Nalapurakkal, Business Area Technology Leader-ESG, Nordea
- Nicola O'Connor, Chief Information Security and IT Risk Officer, AIB
- Jermy Prenio, Principal Advisor, BIS
- Ulku Rowe, Technical Director of Financial Services, Google Cloud
- Daniela Schackis, Deputy Director General, European Central Bank
- Michael Schmelzer, NFPE CFO, Nomura
- Dr. Johannes Turner, Director Statistics Department, Oesterreichische Nationalbank (OeNB)
- Dr. Beatrice Weder di Mauro, Professor of International Economics, Graduate Institute of Geneva
- Sabrina Wilson, COO, Copper
About Regnology
Regnology is a leading technology firm on a mission to bring safety and stability to the financial markets. With an exclusive focus on regulatory reporting and more than 7,000 financial institutions, 30 regulators and 20 tax authorities as clients, we’re uniquely positioned to bring greater data quality, efficiency and cost savings to all market participants. With over 700 employees in 12 countries and a unified data ingestion model powering our work, our clients can quickly implement and derive value from our solutions and easily keep pace with ongoing regulatory changes.
Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology.
For more information about Regnology, connect with us on LinkedIn and Twitter.
Visit our website: www.regnology.net
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220928005085/en/
Contact information
Mireille Adebiyi, Chief Marketing Officer, Regnology
info@regnology.net
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Reintroducing Global Blue to Retailers and Shoppers Worldwide19.3.2024 13:19:00 CET | Press release
Taking shopping further through the power of experience Over 40 years ago, Global Blue pioneered the concept of Tax Free Shopping, changing the retail landscape and empowering international shoppers worldwide. Since then, its journey has evolved, now encompassing three families of solutions: Tax Free Shopping, Payments, and Post-Purchase Solutions. Within these industries, Global Blue consistently leverages its integrated software and data to bring value at every step of the journey and take shopping further. Driven by this commitment, Global Blue teams create engaging experiences that foster connections between consumers and brands while simplifying processes, to ensure every customer journey is seamless and intuitive. Through these efforts, Global Blue enables its clients to seize business opportunities, enhance customer loyalty, boost sales, and optimize operations and costs. “At Global Blue, we firmly believe that improving the shopping journey drives performance. This renewed focu
Forge Biologics’ Novel AAV Gene Therapy FBX-101 for Patients with Krabbe Disease is Granted UK’s Innovation Passport Designation19.3.2024 13:00:00 CET | Press release
Forge Biologics, a member of Ajinomoto Bio-Pharma Services and a leading manufacturer of genetic medicines, today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA), the healthcare regulatory body of the United Kingdom (UK), granted Innovation Passport designation to the Company’s novel AAV gene therapy program, FBX-101, to enter the Innovative Licensing and Access Pathway (ILAP). FBX-101 was created for the treatment of patients with Krabbe disease, a rare neurodegenerative disease that is usually fatal in untreated patients by age two. The ILAP is intended to accelerate regulatory and market access interactions in the UK. Maria Escolar, M.D., Forge’s Chief Medical Officer, will discuss the significance of achieving this regulatory designation and present a poster on updated data from REKLAIM, an early phase clinical trial for FBX-101, during the Advanced Therapies 2024 conference being held in London, March 19-20, 2024. “Considering the rapid progression of
SWISSto12 Continues Expansion, Growing Team by 25% and Adding New Production Space19.3.2024 13:00:00 CET | Press release
SWISSto12, one of Europe’s fastest growing aerospace companies and a leading satellite and Radio Frequency product manufacturer, announces its continued global expansion. The company has secured additional production space at its headquarters in Switzerland, increasing the size of its existing site to 5,700m2. In addition, SWISSto12 has welcomed several new Satcom engineering experts to its growing team, which has increased by 25% since the start of 2024 to over 125 employees working across its facilities in Switzerland, Europe and the USA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240318493042/en/ HummingSat I-8 Inmarsat (Photo: Business Wire) SWISSto12 was recently named as one of the world’s “10 Hottest Satellite Companies.” This industry recognition follows the company’s announcement in Q4 2023 of securing over €200 million in customer orders for Radio Frequency subsystems and HummingSat satellites, including from l
Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up19.3.2024 13:00:00 CET | Press release
Mainstay Medical Holdings plc today announced the publication of the 5-year follow up from the ReActiv8-B randomized, sham-controlled, double-blinded trial. There were 126 patients who completed the 5-year follow up, and the published data clearly indicated that ReActiv8® Restorative Neurostimulation is a long-term, effective, durable, and safe therapy. ReActiv8 is the only restorative therapy for patients suffering from non-surgical, mechanical CLBP evidenced by multifidus dysfunction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240319164677/en/ The long-term responses across pain, disability, and health-related quality of life measures are shown in the following graphs. (Graphic: Business Wire) The publication is available here: https://www.sciencedirect.com/science/article/pii/S1094715924000552 The ReActiv8-B study saw multiple patients have their implants removed for resolution of back pain. These removals for success
AngloGold Ashanti Releases Preliminary Unaudited Condensed Consolidated Financial Statements as of and for the Six Months and the Year Ended 31 December 202319.3.2024 12:04:00 CET | Press release
AngloGold Ashanti plc (“AngloGold Ashanti”, “AGA” or the “Company”) is pleased to provide its preliminary unaudited condensed consolidated financial statements as of and for the six months and the year ended 31 December 2023 (the “FY 2023 Earnings Release”). FY 2023 Financial and Operating Update The FY 2023 Earnings Release should be read together with AngloGold Ashanti’s preliminary financial update for the six months and the year ended 31 December 2023, which was published by the Company on 23 February 2024 (the “FY 2023 Preliminary Financial Update”). No changes have been made in the FY 2023 Earnings Release with respect to the production, cost or cash flow information included in the FY 2023 Preliminary Financial Update. The FY 2023 Preliminary Financial Update combined with the FY 2023 Earnings Release provide the Company’s financial and operating update for the six months and the year ended 31 December 2023. Announcement of Annual General Meeting Date The 2024 Annual General Mee
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom